Sartorius Stedim Biotech S.A. press release (SDMHF): 9M Non-GAAP EPS of â¬2.84. – Revenue of â¬2.29B (+4.1% Y/Y). – Guidance for fiscal year 2026 confirmed and partially refined Based on the business performance in the first nine months of 2026 and the continued positive
Sartorius Stedim Biotech S.A. Non-gaap EPS of €2.84, Revenue of €2.29b
Sartorius Stedim Biotech S.A. press release (SDMHF): 9M Non-GAAP EPS of â¬2.84. - Revenue of â¬2.29B (+4.1% Y/Y). - Guidance for fiscal year 2026 confirmed and partially refined Based on the business performance in the first nine months of 2026 and the continued positive